JP2019533803A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533803A5
JP2019533803A5 JP2019508235A JP2019508235A JP2019533803A5 JP 2019533803 A5 JP2019533803 A5 JP 2019533803A5 JP 2019508235 A JP2019508235 A JP 2019508235A JP 2019508235 A JP2019508235 A JP 2019508235A JP 2019533803 A5 JP2019533803 A5 JP 2019533803A5
Authority
JP
Japan
Prior art keywords
capsid
aav
particles
amino acid
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019508235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019533803A (ja
JP7021191B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/046814 external-priority patent/WO2018035059A1/en
Publication of JP2019533803A publication Critical patent/JP2019533803A/ja
Publication of JP2019533803A5 publication Critical patent/JP2019533803A5/ja
Priority to JP2022014629A priority Critical patent/JP2022064980A/ja
Application granted granted Critical
Publication of JP7021191B2 publication Critical patent/JP7021191B2/ja
Priority to JP2023202414A priority patent/JP2024023460A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019508235A 2016-08-15 2017-08-14 Aavを検出するための方法 Active JP7021191B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022014629A JP2022064980A (ja) 2016-08-15 2022-02-02 Aavを検出するための方法
JP2023202414A JP2024023460A (ja) 2016-08-15 2023-11-30 Aavを検出するための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662375314P 2016-08-15 2016-08-15
US62/375,314 2016-08-15
PCT/US2017/046814 WO2018035059A1 (en) 2016-08-15 2017-08-14 Methods for detecting aav

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022014629A Division JP2022064980A (ja) 2016-08-15 2022-02-02 Aavを検出するための方法

Publications (3)

Publication Number Publication Date
JP2019533803A JP2019533803A (ja) 2019-11-21
JP2019533803A5 true JP2019533803A5 (enExample) 2020-09-24
JP7021191B2 JP7021191B2 (ja) 2022-02-16

Family

ID=59762045

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019508235A Active JP7021191B2 (ja) 2016-08-15 2017-08-14 Aavを検出するための方法
JP2022014629A Pending JP2022064980A (ja) 2016-08-15 2022-02-02 Aavを検出するための方法
JP2023202414A Pending JP2024023460A (ja) 2016-08-15 2023-11-30 Aavを検出するための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022014629A Pending JP2022064980A (ja) 2016-08-15 2022-02-02 Aavを検出するための方法
JP2023202414A Pending JP2024023460A (ja) 2016-08-15 2023-11-30 Aavを検出するための方法

Country Status (22)

Country Link
US (5) US11698377B2 (enExample)
EP (2) EP3851449A1 (enExample)
JP (3) JP7021191B2 (enExample)
KR (5) KR102922101B1 (enExample)
CN (2) CN118688363A (enExample)
AU (2) AU2017312951B2 (enExample)
CA (1) CA3033856A1 (enExample)
CL (2) CL2019000392A1 (enExample)
CR (1) CR20190127A (enExample)
CY (1) CY1124364T1 (enExample)
DK (1) DK3497207T3 (enExample)
ES (1) ES2863674T3 (enExample)
HU (1) HUE053747T2 (enExample)
IL (3) IL264819B2 (enExample)
MA (1) MA55748A (enExample)
MX (2) MX2019001938A (enExample)
PH (1) PH12019500316A1 (enExample)
SG (2) SG10201913002QA (enExample)
TN (1) TN2019000047A1 (enExample)
TW (2) TW202309068A (enExample)
WO (1) WO2018035059A1 (enExample)
ZA (2) ZA201900945B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201508026D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Capsid
HUE053747T2 (hu) 2016-08-15 2021-07-28 Genzyme Corp Eljárások AAV kimutatására
RS65241B1 (sr) * 2017-02-28 2024-03-29 Univ Pennsylvania Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
EP3768695A4 (en) * 2018-02-27 2022-04-06 The Trustees of the University of Pennsylvania NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS WITH REDUCED CAPSIID DEAMIDATION AND USES THEREOF
IL276859B2 (en) * 2018-02-27 2025-12-01 Univ Pennsylvania Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor
EP3762500A1 (en) * 2018-03-06 2021-01-13 Voyager Therapeutics, Inc. Insect cell manufactured partial self-complementary aav genomes
US11391707B2 (en) * 2018-07-27 2022-07-19 Waters Technologies Corporation Liquid chromatography/mass spectrometry methods for the analysis of polar molecules
US12195745B2 (en) * 2018-08-21 2025-01-14 Massachusetts Eye And Ear Infirmary Compositions and methods for modulating transduction efficiency of adeno-associated viruses
WO2020086893A1 (en) 2018-10-25 2020-04-30 Regeneron Pharmaceuticals, Inc. Methods for analysis of viral capsid protein composition
ES2965341T3 (es) * 2019-04-11 2024-04-12 Regenxbio Inc Métodos de cromatografía de exclusión por tamaño para la caracterización de composiciones de virus adenoasociados recombinantes
US11841352B2 (en) * 2019-07-31 2023-12-12 Thermo Finnigan Llc Determination and correction of retention time and mass/charge shifts in LC-MS experiments
EP4085255A1 (en) * 2020-01-03 2022-11-09 Sarepta Therapeutics, Inc. Methods for analyzing aav capsid proteins
WO2021155137A1 (en) 2020-01-29 2021-08-05 Genzyme Corporation Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof
CN111517359B (zh) * 2020-04-23 2021-08-20 江南大学 一种手性硫化铜超粒子的合成方法
RU2748540C1 (ru) * 2021-02-08 2021-05-26 Автономная некоммерческая образовательная организация высшего образования "Сколковский институт науки и технологий" Способ детектирования вируса SARS-CoV-2 методом масс-спектрометрии
US20220268783A1 (en) * 2021-02-19 2022-08-25 Waters Technologies Corporation Methods for peptide mapping of adeno-associated virus (aav) proteins
WO2022224965A1 (ja) * 2021-04-20 2022-10-27 株式会社ユニバーサル・バイオサンプリング 検体保持カード及びそれを用いた検体の検査方法
JP2024525686A (ja) * 2021-07-12 2024-07-12 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Aavカプシド比を決定するための液体クロマトグラフィーアッセイ
CA3225360A1 (en) * 2021-07-12 2023-01-19 Victoria COTHAM Online native mass spectrometry methods for assaying viral particles
CN113552349B (zh) * 2021-07-30 2022-07-19 上海勉亦生物科技有限公司 Aav蛋白外壳的检测方法
EP4462114A4 (en) * 2022-01-06 2025-04-16 FUJIFILM Corporation Method and kit for identifying sugar-bound amino acid site in protein
US20250110119A1 (en) * 2023-03-03 2025-04-03 Sartorius Bioanalytical Instruments, Inc. Methods for quantitating viral capsids
WO2024263520A1 (en) * 2023-06-19 2024-12-26 Regeneron Pharmaceuticals, Inc. Host cell protein analysis for adeno-associated virus (aav)-based gene therapy
AU2024378556A1 (en) * 2023-11-08 2026-05-21 Oxford Biomedica (Us) Llc Deamidation depleted adeno-associated virus product

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540931A (en) 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US6204059B1 (en) * 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
CA2264482A1 (en) 1996-09-06 1998-03-12 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6995006B2 (en) 1997-09-05 2006-02-07 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6596535B1 (en) 1999-08-09 2003-07-22 Targeted Genetics Corporation Metabolically activated recombinant viral vectors and methods for the preparation and use
US7465583B2 (en) 2000-06-01 2008-12-16 The University Of North Carolina At Chapel Hill Duplexed parvovirus vectors
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
SI1496944T1 (sl) 2002-05-01 2009-02-28 Univ Florida Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov
WO2004049385A2 (en) 2002-11-22 2004-06-10 Caprion Pharmaceuticals, Inc. Constellation mapping and uses thereof
US7510872B2 (en) 2003-02-26 2009-03-31 Nationwide Children's Hospital Recombinant adeno-associated virus production
JP4559429B2 (ja) 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
EP1486567A1 (en) 2003-06-11 2004-12-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved adeno-associated virus (AAV) vector for gene therapy
US9441244B2 (en) * 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US8283151B2 (en) 2005-04-29 2012-10-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
PT3272872T (pt) 2005-10-20 2020-06-26 Uniqure Ip Bv Vetores aav melhorados produzidos em células de insetos
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
EP2342567A1 (en) 2008-09-19 2011-07-13 Charité Universitätsmedizin Berlin Identification and characterisation of recombinant viral gene therapy vectors
EP2396343B1 (en) 2009-02-11 2017-05-17 The University of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
JP5956331B2 (ja) 2009-06-16 2016-07-27 ジェンザイム・コーポレーション 組換えaavベクターの改良された精製方法
DK2561073T3 (en) 2010-04-23 2016-12-12 Univ Massachusetts Aav vectors targeted to central nervous system and methods of use thereof
US20130217789A1 (en) * 2010-09-03 2013-08-22 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
US8663624B2 (en) 2010-10-06 2014-03-04 The Regents Of The University Of California Adeno-associated virus virions with variant capsid and methods of use thereof
CN103502458B (zh) 2011-02-17 2016-11-16 宾夕法尼亚大学托管会 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法
EP3795581A3 (en) 2011-08-24 2021-06-09 The Board of Trustees of the Leland Stanford Junior University New avv capsid proteins for nucleic acid transfer
JP6342886B2 (ja) * 2012-04-18 2018-06-13 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
US20140017716A1 (en) * 2012-07-11 2014-01-16 Siscapa Assay Technologies, Inc. Proteolytic digestion kit with dried reagents
GB201401707D0 (en) 2014-01-31 2014-03-19 Sec Dep For Health The Adeno-associated viral vectors
WO2015137802A1 (en) * 2014-03-10 2015-09-17 Uniqure Ip B.V. Further improved aav vectors produced in insect cells
HUE053747T2 (hu) 2016-08-15 2021-07-28 Genzyme Corp Eljárások AAV kimutatására

Similar Documents

Publication Publication Date Title
JP7698624B2 (ja) 空のおよび完全なウイルスキャプシド粒子の分離および定量化
JP2021516046A5 (enExample)
ES2580044T3 (es) Método de incremento de la función de un vector de AAV
CN105636981B (zh) 腺相关病毒因子viii载体
KR20190032375A (ko) 신규 아데노-관련 바이러스 캡시드 단백질
CN113874385A (zh) 突变的腺相关病毒衣壳蛋白、包含该蛋白的aav颗粒和肝定向aav载体基因治疗
JP2022520803A5 (enExample)
JP2017509632A5 (enExample)
HRP20192141T1 (hr) Genska terapija za retinitis pigmentosa
CN110168080A (zh) 检测aav的方法
EP4172322A1 (en) Improved adeno-associated virus gene therapy vectors
JP2025517628A5 (enExample)
JP2023524024A5 (enExample)
EP3924364A1 (en) Compositions and methods for producing recombinant aav
JP7488281B2 (ja) 組換えアデノ随伴ウイルス組成物の特性評価のためのサイズ排除クロマトグラフィーの方法
Sorroza-Martinez et al. Recent advances in therapeutics and manufacturing processes of recombinant adeno-associated virus for the treatment of lung diseases
US20240271160A1 (en) Production of adeno-associated virus vector in insect cells
EP4644556A1 (en) Method for producing adeno-associated virus, and vector set
RU2022110175A (ru) Способы выявления aav
US20260028598A1 (en) Method for separating full and empty AAV particles
WO2025228321A1 (en) METHOD OF SEPARATING RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV) PARTICLES
TW202600829A (zh) 重組核酸分子、包括其的載體和宿主細胞、其用途及生產重組aav的方法
WO2025207456A1 (en) Methods for purification of adeno associated virus particles by anion exchange chromatography
HK40119481A (en) Method for separating full and empty aav particles
HK40106196A (en) Production of adeno-associated virus vector in insect cells